News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
94,094 Results
Type
Article (5422)
Company Profile (60)
Press Release (88612)
Section
Business (32758)
Career Advice (215)
Deals (5272)
Drug Delivery (12)
Drug Development (16616)
Employer Resources (19)
FDA (1586)
Job Trends (2269)
News (53864)
Policy (2975)
Tag
Academia (279)
Alliances (7325)
Alzheimer's disease (93)
Antibody-drug conjugate (ADC) (42)
Approvals (1596)
Artificial intelligence (19)
Bankruptcy (25)
Best Places to Work (1847)
Biotechnology (45)
Breast cancer (49)
Cancer (477)
Career advice (182)
CAR-T (29)
Cell therapy (98)
Clinical research (12940)
Collaboration (99)
Compensation (30)
COVID-19 (315)
C-suite (28)
Data (278)
Diagnostics (921)
Earnings (14125)
Events (15527)
Executive appointments (62)
FDA (1679)
Funding (92)
Gene editing (20)
Gene therapy (23)
GLP-1 (97)
Government (346)
Healthcare (2807)
Infectious disease (323)
Interviews (35)
IPO (2685)
Job creations (468)
Job search strategy (148)
Layoffs (79)
Legal (399)
Liver cancer (20)
Lung cancer (79)
Lymphoma (20)
Manufacturing (35)
Medical device (988)
Medtech (988)
Mergers & acquisitions (2634)
Metabolic disorders (37)
Neuroscience (123)
NextGen Class of 2024 (798)
Non-profit (270)
Northern California (406)
Obesity (20)
Opinion (27)
Ovarian cancer (27)
Patents (26)
People (9541)
Phase I (6341)
Phase II (5865)
Phase III (2993)
Pipeline (158)
Postmarket research (109)
Preclinical (2033)
Press Release (28)
Radiopharmaceuticals (101)
Rare diseases (23)
Real estate (783)
Regulatory (2434)
Research institute (352)
Resumes & cover letters (39)
Series A (22)
Southern California (428)
Startups (776)
United States (2649)
Vaccines (67)
Date
Today (27)
Last 7 days (165)
Last 30 days (858)
Last 365 days (7790)
2024 (7103)
2023 (8723)
2022 (10427)
2021 (10427)
2020 (8614)
2019 (5946)
2018 (4545)
2017 (4860)
2016 (4043)
2015 (4694)
2014 (3140)
2013 (2386)
2012 (2817)
2011 (2834)
2010 (2441)
Location
Africa (77)
Asia (6941)
Australia (972)
California (912)
Canada (227)
China (81)
Colorado (25)
Connecticut (29)
Delaware (23)
Europe (12953)
Florida (74)
Illinois (49)
Indiana (33)
Japan (22)
Maryland (82)
Massachusetts (502)
Minnesota (42)
New Jersey (169)
New York (189)
North Carolina (131)
Northern California (406)
Ohio (25)
Pennsylvania (112)
South America (109)
Southern California (428)
Texas (112)
Washington State (59)
94,094 Results for "solid biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Solid Biosciences to Present at the Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Solid Biosciences Joins the Russell 3000® Index
Solid Biosciences Inc. announced that the Company has been added to the broad-market Russell 3000® Index as part of the annual reconstitution, effective at the open of US equity markets, Monday, July 1st 2024.
July 1, 2024
·
5 min read
Press Releases
Solid Biosciences to Participate at the Truist Securities BioPharma Symposium
October 31, 2024
·
1 min read
Press Releases
Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 7, 2024
·
10 min read
Press Releases
Solid Biosciences to Participate at Upcoming Investor Conferences
September 4, 2024
·
1 min read
Business
Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results
Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today reported financial results for the first quarter ended March 31, 2024, and provided a business update.
May 15, 2024
·
8 min read
Genetown
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024
Solid Biosciences Inc., a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, announced grants of 30,949 restricted stock units to four newly hired employees.
June 4, 2024
·
1 min read
Biotech Bay
AmplifyBio and Xcell Biosciences Announce Partnership to Manufacture Solid Tumor-Targeting TCR-T Cell Therapy
Xcell Biosciences Inc. and AmplifyBio today announced the launch of a partnership designed to streamline and improve the manufacturing process for engineered T-cell receptor (TCR) therapies targeting solid tumors.
May 20, 2024
·
4 min read
Press Releases
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 4, 2024
November 5, 2024
·
1 min read
Press Releases
Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference
September 12, 2024
·
1 min read
1 of 9,410
Next
